Literature DB >> 10455077

Cystic medial degeneration of the aorta is associated with p53 accumulation, Bax upregulation, apoptotic cell death, and cell proliferation.

C Ihling1, T Szombathy, K Nampoothiri, J Haendeler, F Beyersdorf, M Uhl, A M Zeiher, H E Schaefer.   

Abstract

OBJECTIVE: To address a potential role for p53, Bcl2 associated protein X (Bax), and apoptosis in the processes associated with cell turnover during cystic medial degeneration (CMD) of the aorta.
METHODS: Histochemical, immunohistochemical, biochemical, and morphometric methods were used to assess the presence and distribution of p53 immunoreactivity (p53-IR) and Bax immunoreactivity (Bax-IR), as well as the presence of apoptosis and tissue repair processes.
RESULTS: Immunohistochemical staining disclosed evidence for p53-IR in all specimens in 26.1 (11.5)% of vascular smooth muscle cells (VSMCs) (controls 0.8 (1.3)%; p < 0. 001). Bax-IR was present in all specimens in 10 (5.4)% of medial cells (controls 0.3 (0.5)%; p < 0.001). Medial VSMCs (alpha-actin positive) with cytoplasmic staining for an apoptosis specific protein (c-jun/ASP) were present in 20/20 specimens (0.7 (0.6)% of VSMCs, controls 0%, p < 0.001), whereas terminal deoxynucleotidyl transferase mediated dUTP-biotin nick end labeling (TUNEL) positive VSMCs were present in 17/20 specimens (1 (1.5)% of VSMCs, controls 0%, p < 0.001). The presence of apoptosis was confirmed by electron microscopy and the demonstration of oligonucleosomal DNA fragments after agarose gel electrophoresis. As shown by double labeling and investigation of serial sections, p53-IR, Bax-IR, c-jun/ASP-IR, and positive TUNEL labeling localised to the same compartments of the aortic media, raising a possible role for p53 and Bax in the triggering of apoptosis of VSMC during CMD. MIB1/Ki-67 positive medial VSMCs (alpha-actin positive) and mesenchymal cells (vimentin positive) were present in all specimens (2.5 (2.8)% of medial cells; controls 0.3 (0.9)%, p < 0.001) mainly in the region around the vasa vasorum, indicating that cell regeneration during CMD may originate mainly from the mesenchyme surrounding the vasa vasorum.
CONCLUSION: This study shows that the formal pathogenesis of CMD is characterised by p53 accumulation, Bax upregulation, cell death by apoptosis, and cell regeneration. Nevertheless, the precise stimuli of p53 activation and Bax upregulation as well as the role of p53 and apoptosis in the dissection process itself remain elusive.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10455077      PMCID: PMC1729171          DOI: 10.1136/hrt.82.3.286

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  38 in total

1.  Shrinkage necrosis: a distinct mode of cellular death.

Authors:  J F Kerr
Journal:  J Pathol       Date:  1971-09       Impact factor: 7.996

Review 2.  Aortic dissection.

Authors:  R W DeSanctis; R M Doroghazi; W G Austen; M J Buckley
Journal:  N Engl J Med       Date:  1987-10-22       Impact factor: 91.245

3.  Identification of a p53-dependent negative response element in the bcl-2 gene.

Authors:  T Miyashita; M Harigai; M Hanada; J C Reed
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

4.  p53 expression during normal tissue regeneration in response to acute cutaneous injury in swine.

Authors:  H N Antoniades; T Galanopoulos; J Neville-Golden; C P Kiritsy; S E Lynch
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

5.  Pathogenesis of dissecting aneurysm of aorta. Comparative histopathologic study of significance of medial changes.

Authors:  T J Schlatmann; A E Becker
Journal:  Am J Cardiol       Date:  1977-01       Impact factor: 2.778

6.  Histologic changes in the normal aging aorta: implications for dissecting aortic aneurysm.

Authors:  T J Schlatmann; A E Becker
Journal:  Am J Cardiol       Date:  1977-01       Impact factor: 2.778

7.  Risk factors for aortic dissection: a necropsy study of 161 cases.

Authors:  E W Larson; W D Edwards
Journal:  Am J Cardiol       Date:  1984-03-01       Impact factor: 2.778

Review 8.  Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias.

Authors:  T N James
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

Review 9.  Relationship of p53 to the control of apoptotic cell death.

Authors:  M Oren
Journal:  Semin Cancer Biol       Date:  1994-06       Impact factor: 15.707

10.  Co-expression of p53 and MDM2 in human atherosclerosis: implications for the regulation of cellularity of atherosclerotic lesions.

Authors:  C Ihling; J Haendeler; G Menzel; R D Hess; G Fraedrich; H E Schaefer; A M Zeiher
Journal:  J Pathol       Date:  1998-07       Impact factor: 7.996

View more
  20 in total

1.  Klf15 deficiency is a molecular link between heart failure and aortic aneurysm formation.

Authors:  Saptarsi M Haldar; Yuan Lu; Darwin Jeyaraj; Daiji Kawanami; Yingjie Cui; Sam J Eapen; Caili Hao; Yan Li; Yong-Qiu Doughman; Michiko Watanabe; Koichi Shimizu; Helena Kuivaniemi; Junichi Sadoshima; Kenneth B Margulies; Thomas P Cappola; Mukesh K Jain
Journal:  Sci Transl Med       Date:  2010-04-07       Impact factor: 17.956

2.  Rare copy number variants disrupt genes regulating vascular smooth muscle cell adhesion and contractility in sporadic thoracic aortic aneurysms and dissections.

Authors:  Siddharth K Prakash; Scott A LeMaire; Dong-Chuan Guo; Ludivine Russell; Ellen S Regalado; Hossein Golabbakhsh; Ralph J Johnson; Hazim J Safi; Anthony L Estrera; Joseph S Coselli; Molly S Bray; Suzanne M Leal; Dianna M Milewicz; John W Belmont
Journal:  Am J Hum Genet       Date:  2010-11-18       Impact factor: 11.025

Review 3.  Matrix metalloproteinases and descending aortic aneurysms: parity, disparity, and switch.

Authors:  Tom P Theruvath; Jeffrey A Jones; John S Ikonomidis
Journal:  J Card Surg       Date:  2011-09-29       Impact factor: 1.620

4.  Ascending aorta dilatation in aortic valve disease: morphological analysis of medial changes.

Authors:  Lucio Agozzino; Pasquale Santè; Franca Ferraraccio; Marina Accardo; Marisa De Feo; Luca Salvatore De Santo; Gianantonio Nappi; Manuela Agozzino; Salvatore Esposito
Journal:  Heart Vessels       Date:  2006-07       Impact factor: 2.037

Review 5.  Non-coding RNAs: key regulators of smooth muscle cell fate in vascular disease.

Authors:  Nicholas J Leeper; Lars Maegdefessel
Journal:  Cardiovasc Res       Date:  2018-03-15       Impact factor: 10.787

Review 6.  Spontaneous arterial dissection: phenotype and molecular pathogenesis.

Authors:  Caspar Grond-Ginsbach; Rastislav Pjontek; Suna Su Aksay; Alexander Hyhlik-Dürr; Dittmar Böckler; Marie-Luise Gross-Weissmann
Journal:  Cell Mol Life Sci       Date:  2010-02-14       Impact factor: 9.261

Review 7.  Molecular pathogenesis of genetic and sporadic aortic aneurysms and dissections.

Authors:  Ying H Shen; Scott A LeMaire
Journal:  Curr Probl Surg       Date:  2017-02-03       Impact factor: 1.909

8.  Cellular phenotype transformation occurs during thoracic aortic aneurysm development.

Authors:  Jeffrey A Jones; Juozas A Zavadzkas; Eileen I Chang; Nina Sheats; Christine Koval; Robert E Stroud; Francis G Spinale; John S Ikonomidis
Journal:  J Thorac Cardiovasc Surg       Date:  2010-03-09       Impact factor: 5.209

9.  Chronic mTOR activation induces a degradative smooth muscle cell phenotype.

Authors:  Guangxin Li; Mo Wang; Alexander W Caulk; Nicholas A Cilfone; Sharvari Gujja; Lingfeng Qin; Pei-Yu Chen; Zehua Chen; Sameh Yousef; Yang Jiao; Changshun He; Bo Jiang; Arina Korneva; Matthew R Bersi; Guilin Wang; Xinran Liu; Sameet Mehta; Arnar Geirsson; Jeffrey R Gulcher; Thomas W Chittenden; Michael Simons; Jay D Humphrey; George Tellides
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

10.  Copy number variation in patients with cervical artery dissection.

Authors:  Caspar Grond-Ginsbach; Bowang Chen; Rastislav Pjontek; Tina Wiest; Yanxiang Jiang; Barbara Burwinkel; Sandrine Tchatchou; Michael Krawczak; Stefan Schreiber; Tobias Brandt; Manja Kloss; Marie-Luise Arnold; Kari Hemminki; Christoph Lichy; Philippe A Lyrer; Ingrid Hausser; Stefan T Engelter
Journal:  Eur J Hum Genet       Date:  2012-05-23       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.